ELAN Stock Analysis: Buy, Sell, or Hold?
ELAN - Elanco Animal Health Incorporated Common Stock
$25.72
-0.65 (-2.46%)
▼
5d:
+1.22%
30d:
+2.88%
90d:
+14.26%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 05, 2026
1d
Get Alerted When ELAN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ELAN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: ELAN shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$37.01
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$22.98
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELAN is currently trading at $25.72, which is considered slightly high relative to its 30-day fair value range of $24.59 to $25.82. The stock's valuation (Forward PE: 22.1) is in line with its historical norms (21.0). At these levels, the market is pricing in 1.6% annual earnings growth.
Technical Outlook: Technically, ELAN is in a uptrend. Immediate support is located at $24.59, while resistance sits at $26.87.
Market Sentiment: ELAN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.07 (+14.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELAN is in a uptrend. Immediate support is located at $24.59, while resistance sits at $26.87.
Market Sentiment: ELAN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.07 (+14.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$24.59 -
$25.82
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($30.07)
- BULLISH: Expecting earnings turnaround to 1.6% growth with 14.9% revenue growth
Trading Range Analysis
30-Day Trading Range
$24.59 -
$25.82
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.59
Resistance Level
$26.87
Current Trend
Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
22.05
Wall Street Target
$30.07
(+14.0%)
Revenue Growth (YoY)
14.9%
Earnings Growth (YoY)
-15.4%
Profit Margin
-5.0%
Valuation Premium vs History
+1.6% premium
PE vs Historical
22.1 vs 21.0
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+1.6%
(market-implied from PE analysis)
1-Year Target
$26.79
(+2%)
2-Year Target
$27.22
(+3%)
3-Year Target
$27.66
(+5%)
3-Yr Target (if PE normalizes)
(PE: 22→21)
PE COMPRESSION
$26.34
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.0, Growth: 12.2%)
$37.27
(+41%)
Base:
(SPY PE: 20.7, Growth: 12.2%)
$35.05
(+33%)
Bear:
(PE: 17.6, Growth: 12.2%)
$29.79
(+13%)
Share & Embed Analysis
Last updated: August 03, 2026 4:24 PM ET
Data refreshes hourly during market hours. Next update: 5:24 PM
Data refreshes hourly during market hours. Next update: 5:24 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELAN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$211 | 60 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$112 | 52 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$663 | 48 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$113 | 45 HOLD |
|
AVDL
Avadel Pharmaceuticals P… |
STRONG BUY
8 analysts |
$21 | 62 BUY |
Advanced ELAN Option Strategies
Professional options setups generated by AI based on today's ELAN price and gamma walls.
